KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growthKazuhide Nakamura, Toshiyuki Isoe|Molecular Cancer Therapeutics|2004Cited by 66
Synergistic anti-AML effects of the LSD1 inhibitor T-3775440 and the NEDD8-activating enzyme inhibitor pevonedistat via transdifferentiation and DNA rereplicationYoshinori Ishikawa, Kazuhide Nakamura|Oncogenesis|2017Cited by 38
Panitumumab interaction with<scp>TAS</scp>‐102 leads to combinational anticancer effects via blocking of<scp>EGFR</scp>‐mediated tumor response to trifluridineYuji Baba, Kazuhide Nakamura|Molecular Oncology|2017Cited by 22